‼️See below terrific opportunity for a postdoc post with a leading group in Oxford, super exciting science! 🔥🔥👇

thanks for highlighting our study @erictopol.bsky.social !

Thrilled that our paper is in print @science.org!! *Platelets sequester cell free DNA, including free fetal and tumour-derived DNA* Tweetorial from @l-cmurphy.bsky.social below. Check out the news feature science.org/content/arti... and terrific editorial from Dennis Lo #platelets_in_the_limelight

MPN community (patients/families) - do join us with MPN voice tomorrow if you are interested to hear updates on all the exciting data presented at the recent European Haematology Congress @mpnvoice.bsky.social @mpnrf.bsky.social www.mpnvoice.org.uk/news/mpn-voi...

Exciting times for mutCALR MPNs - lovely data from the ET cohort presented in late breaking abstract at @EHA_Hematology. Rapid platelet control after just 2 doses with 89% of patients benefitting from a molecular response with INCA033989. @mpnvoice.bsky.social @mpnrf.bsky.social @mpnhv.bsky.social

Exciting job opportunities here for *TWO* computational researchers to contribute to a new collaborative effort between the @imm.ox.ac.uk and @ludwigcancer.bsky.social focussing on progression to high risk blood cancers and secondary leukaemia. Come join our brilliant team!

Lovely sunset family picnic serenaded by the geese at the Costa Del Port Meadow. #beautifuloxford

We are recruiting!! Ads now live for a Data Coordinator and 2 Research Assistants/biobankers to join a new @ludwigcancer.bsky.social - @imm.ox.ac.uk joint initiative to prevent progression from early- to advanced blood cancer. Joint posts with Adam Mead+others in Oxford Ludwig. Links below

Thrilled to share new work led by @jieyang437.bsky.social in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre rdcu.be/eci1U

Rare Disease Day is coming up this Friday (28th Feb) 🧪 We spoke with Sarah Gooding, a clinician scientist in @rosschapmanlab.bsky.social's group at the MRC WIMM researching multiple myeloma - a currently incurable type of bone marrow cancer that desperately requires friendlier therapies.

Check out @imm.ox.ac.uk latest video on innovation - we are fortunate to work in such a dynamic environment, bridging biological discovery and clinical translation @ox.ac.uk @cancerresearchuk.org

Check out @abattacks.bsky.social’s new and improved bone marrow organoid model - preprint below. More cell types (lymphoid progenitors and osteo- lineage), myeloma modelling and a cool method to improve scalability!

Hugely well deserved @ckbrierley.bsky.social

Super proud of brilliant NIH-OxCAM PhD student ZoeWong for winning the Doug Higgs Best Abstract award at Oxford Centre for Haematology Day @ox.ac.uk @ouhospitals.bsky.social @imm.ox.ac.uk, for her collab project with @alexrampotas.bsky.social. They are racking up prizes betw them…paper coming!

Great paper from @immunothrombosis.bsky.social group - platelets alter their functional properties with time since thrombogenesis. Important implications for transfusion storage time!

Join Us for the MPN Voice Virtual Forum! 🗓 Date: Monday, 6 January 2025 🕒 Time: 4:30 PM – 6:00 PM (GMT)📍 Location: Online (Zoom). Registration is now open! Focusing on the latest updates from the American Society of Hematology (ASH). linktr.ee/Mpnvoice

So proud of DrLaurenMurphy passing PhD @imm.ox.ac.uk with flying colours.Grateful that she was brave enough to join as 2nd lab recruit 6yrs ago, and determined enough to make a huge success of a high-risk-high-reward PhD inspired by a @cancerresearchuk.org sandpit!Thanks examiners ProfsCurry&Gibbins

Excited for this session!

Make sure to get your talk submissions in! Can't wait for this conference and the all-star speakers/science!!

Terrific talk from the brilliant @antoniorromera.bsky.social this morning on how cells tolerate whole genome duplication and implications for cancer evolution. Check it out on the virtual platform if you missed it!

Very well deserved @alexrampotas.bsky.social ! We are thrilled to work with you and the CAR-T team

Very pleased to present the results of a UK wide collaborative study on real world efficacy and safety of Momelotininb - >60% anaemia responses at 6 months -G1-2 peripheral neuropathy (15%) -unexpected thrombocytosis (?hepcidin dysregulation due to AVCR1 inhibition) #ASH24 @bethpsaila.bsky.social

Sunrise and moonset beyond the Coronado Bridge on a beautiful run around San Diego bay this morning

All packed and ready for #ASH24 @ash-hematology.bsky.social! Just trying to decide which essential item to leave behind to get my suitcase to close

Check out our “In a Nutshell” review in Brit J Haem - When, Which and How to Switch - navigating JAK inhibitors for myelofibrosis onlinelibrary.wiley.com/doi/10.1111/...

Excited for #ASH24 & thrilled that *3* brilliant folks from the team have oral presentations, travel awards and 2/3 nominated for **best of ASH**!! @imm.ox.ac.uk @ox.ac.uk @cancerresearchuk.org @ludwigcancer.bsky.social